Biggest News Aggregation in the World
📰 Bymark Leiser News

Page 2 - Bymark Leiser News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Bymark Leiser. Real-time updates on events, politics, business and more.

Biomarkers predict benefit of adjuvant nivolumab in resected melanoma

CHICAGO — Several biomarkers predicted outcomes with adjuvant nivolumab vs. placebo for patients with resected stage IIB or IIC melanoma, according to study results presented at ASCO Annual Meeting.In contrast to prior findings in melanoma, no biomarkers appeared prognostic for RFS among patients who received placebo.
United States Western Australia Bymark Leiser Castle Biosciences Brian Gastman Bristol Myers Squibb
Source: healio.com

NCI director: 'Committed and collective action' required to achieve Moonshot goal

CHICAGO — “Committed and collective action” will be required if a key goal of the Cancer Moonshot — reducing cancer mortality by at least 50% in 25 years — will be met, the NCI director told ASCO Annual Meeting attendees.“We won’t succeed if we stay in our silos, and we won’t succeed by pointing fingers,” Monica M. Bertagnolli, MD, FACS,
United States Monicam Bertagnolil Monicam Bertagnolli Bymark Leiser Grupo Oncolinicas Incyte Astellas Pharma
Source: healio.com

Zanidatamab induces response in refractory HER2-positive biliary tract cancer

CHICAGO — Zanidatamab induced durable responses among patients with previously treated HER2-amplified biliary tract cancer, according to study results presented at ASCO Annual Meeting.The agent also exhibited a manageable safety profile, investigators who conducted the phase 2b HERIZON-BTC-01 study concluded.
United States Astellas Pharma Mindy Valcarcel Bymark Leiser Boehringer Ingelheim Bristol Myers Squibb
Source: healio.com

Pembrolizumab improves outcomes in early-stage resectable lung cancer

CHICAGO — The addition of pembrolizumab to neoadjuvant chemotherapy followed by adjuvant pembrolizumab improved outcomes for patients with early-stage resectable non-small cell lung cancer, according to findings presented at ASCO Annual Meeting.Results of the randomized phase 3 KEYNOTE-671 trial — published simultaneously in The New England Journal of Medicine — showed a
United States Astrazeneca Medimmune Genentech Roche Bymark Leiser Heather Wakelee Mindy Valcarcel
Source: healio.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Some patients with stage III melanoma can avoid surgery after neoadjuvant immunotherapy

CHICAGO — Tumor lymph node dissection likely can be omitted for patients with melanoma who achieve major pathologic response after neoadjuvant immune checkpoint blockade, according to study results presented at ASCO Annual Meeting.Patients who achieve major pathologic response do not need adjuvant systemic therapy; however, adjuvant systemic therapy appears to extend survival for patients
United States Irene Reijers Bymark Leiser Mindy Valcarcel Netherlands Cancer Institute Bristol Myers Squibb
Source: healio.com

Surgeon general: Burnout has many health care workers 'in crisis'

CHICAGO — The escalating prevalence of burnout among U.S. health care providers poses “a real threat” to public health, the U.S. surgeon general told ASCO Annual Meeting attendees.“Many of our health care workers are in crisis,” Vice Admiral Vivek H. Murthy, MD, MBA, said during the meeting’s opening ceremony. “We have burnout rates that have gone through
United States Bymark Leiser Vivekh Murthy Marcella Nunez Smith Health Worker Yale School Of Medicine
Source: healio.com

Chemotherapy after first-line EGFR TKI fails to extend survival in advanced NSCLC

CHICAGO — Platinum-doublet chemotherapy did not extend survival for patients with advanced nonsquamous non-small cell lung cancer who responded to EGFR tyrosine kinase inhibitor therapy, according to randomized phase 3 study results.The regimen prolonged PFS but did not confer an OS benefit, findings presented at ASCO Annual Meeting showed.
United States Chugai Pharma Daiichi Sankyo Mindy Valcarcel Astrazeneca Hong Kong Bymark Leiser
Source: healio.com

Glasgow prognostic score may predict survival in small cell lung cancer

Glasgow prognostic score appeared associated with survival among patients with small cell lung cancer treated with first-line atezolizumab plus carboplatin and etoposide, according to study results.No biomarkers are available to predict effectiveness of first-line therapy with atezolizumab (Tecentriq, Genentech) — an anti-PD-L1 antibody — plus carboplatin and etoposide for patients
Mindy Valcarcel Satoshi Wasamoto Bymark Leiser Hospital Advanced Care Center Saku General Hospital Advanced Care Center
Source: healio.com

AYA cancer survivors treated with cardiotoxic therapies exhibit accelerated cardiac aging

Adolescent and young adult cancer survivors who received cardiotoxic treatments exhibited a high burden of poor cardiac function, according to study results presented at American Association for Cancer Research Annual Meeting. The cross-sectional study included 127 cancer survivors treated with anthracyclines or radiation for Hodgkin lymphoma or sarcoma as adolescents or young adults (AYA).
United States Michelleat Hildebrandt Bymark Leiser Mindy Valcarcel American Association For Cancer Research Annual Meeting University Of Texas Md Anderson Cancer Center
Source: healio.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science